MC
TMO icon

Moors & Cabot’s Thermo Fisher Scientific TMO Stock Holding History

Moors & Cabot’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-10,119
Closed -$29K – 700
2019
Q3 		$29K Buy
+10,119
New +$2.9M ﹤0.01% 635

Other funds holding TMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Moors & Cabot's TMO Position: Q1 2026 in Review

Moors & Cabot reduced its Thermo Fisher Scientific (TMO) stake by 1.5% in Q1 2026, selling an estimated $25.5K and leaving 3,139 shares worth $1.54M. The position accounts for 0.07% of the portfolio, ranked #264.

Moors & Cabot first reported a position in TMO in Q3 2015 and has held it in 43 quarters since. The position peaked at $3.98M in Q4 2021. 2,588 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Moors & Cabot held 3,139 shares of Thermo Fisher Scientific worth $1.54M as of Q1 2026.
  • Moors & Cabot sold 47 Thermo Fisher Scientific shares in Q1 2026, an estimated $25.5K.
  • Thermo Fisher Scientific made up 0.07% of Moors & Cabot's portfolio in Q1 2026, its #264 holding.
  • Moors & Cabot first reported a position in Thermo Fisher Scientific in Q3 2015 and has held it in 43 quarters since.
  • Moors & Cabot's Thermo Fisher Scientific position peaked at $3.98M in Q4 2021.
  • 2,588 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Moors & Cabot's 13F filing for Q1 2026, filed 8 May 2026.